Good Morning,
Welcome to this week’s exclusive edition of our longevity investment digest.
Longevity is on track to be the most valuable sector in healthcare, with incredible market value estimates ranging from $600bn (Bank of America) to $2tn (McKinsey) by 2025. The Longevity Investor Report, coordinated by Multi-Fund General Partners, provides a complete sector breakdown focussed on the 10 key longevity investment areas.
The report provides free – for this limited edition – inside access to central notions, and companies, that professional investors are weighing up.
Interested in learning more about this burgeoning investment area?
THE LONGEVITY INVESTOR REPORT
This exclusive first edition has a complete sector breakdown, and an introduction to some of the key things professional longevity investors are looking at.
We’re demystifying the sector, and providing inside access to the most promising companies.
Executive Summary
As longevity establishes itself as an investment category in its own right, there are distinct types of investments, and established categories of company operations. Through watching trends in entrepreneurship, and gauging scientific advancements, it’s possible to divide and assess companies, business models and therefore investment prospects. Longevity is complex, but we hope this guide begins to demystify the whole sector.
Each section includes the key talking points for the category and a guide to what to look for in an investment. By studying the pros and cons of each approach, you’ll be able to assess what the companies say about themselves, and their likely prospects as this market matures. For most investors it’s a matter of asking the right questions.
For all the scientific excitement around longevity, and the exploding levels of investment in the industry – this is no different from any other kind of investment decision. Due diligence, patience and careful selection are essential. The key is asking the right questions.
In this report, we will cover the top 10 most important categories within longevity investment.
Henri Sant-Cassia
Founding Partner, Longr
“Our favorite holding period is forever.”
Warren Buffett, Investor
Longr Reads’ of the Week
- ‘Aging is a disease’: Inside the drive to postpone death indefinitely (Washington Post)
- The Future of Aging (Deloitte)
- The Longevity Society (The Lancet)